Contact Us

Consulting Services

+44 (1344) 601324
US: +1 203 291-9109

In the News

Putting Predictive Market Research to the Test

Maximize marketing investments through more accurate forecasting - Pharmaceutical Executive, April 2009

Read more

Hot Topics

Seeing solutions today.
Celebrating success tomorrow.

In today’s climate, it’s hard to tell the difference between an obstacle and an opportunity. Quintiles Consulting can help. We draw on deep, multi-dimensional industry experience to create strategies for your business, now and in the future.

Here you will find our insights on critical issues and key challenges facing organizations like yours. It’s time for transformation and you can trust Quintiles to guide the way to success not just for your company and your customers — but more important — for the patients whose lives you improve every day with your innovations.

Making change happen

In this dynamic market, defining and then implementing the changes needed to sustain your business and excel in the face of future demands is difficult to achieve. Here are two approaches for driving transformation.

New risk-reward models for transforming development
New models to rebalance risk and transform development can help improve productivity and reduce costs.
Learn more

Life cycle approaches for commercialization
By using life cycle resource approach to commercialization, organizations can promote commercialization flexibility and productivity.
Learn more

Getting the most value

Being able to fully exploit the potential of your  business investments as well as define fair market valuation for your products is a difficult task, even in the best of times. Here are some insights on maximizing value

Evidence-based decision making
In the changing landscape of drug development better, evidence-based decisions, combined  with smart sourcing strategies, will differentiate the future winners.
Learn more

Setting a new pricing standard
A health economic balance sheet and evidence-based pricing can help promote uniform information for biopharmaceutical valuation.
Learn more